Dark

KALV
KalVista Pharmaceuticals, Inc. Common Stock
stock NASDAQ

Inactive

Jun 10, 2026

27.00USD+0.037%(+0.01)4,272,770

Pre-market

0.00USD-100.000%(-26.99)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

CEO

Thomas Crockett

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Last Split

Nov 22, 20161for14reverse

XENT EYEG KOOL SNOA XLV

Profile

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.